Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Zhaoming Li; Yue Song; Yanjie Zhang; Chaoping Li; Yingjun Wang; Weili Xue; Lisha Lu; Mengyuan Jin; Zhiyuan Zhou; Xinhua Wang; Ling Li; Lei Zhang; Xin Li; Xiaorui Fu; Zhenchang Sun; Jingjing Wu; Xudong Zhang; Hui Yu; Feifei Nan; Yu Chang; Jiaqin Yan; Xiaoyan Feng; Xiaolong Wu; Guannan Wang; Dandan Zhang; Wencai Li; Feixiang Li; Yuan Zhang; Ken H. Young; Mingzhi Zhang

doi:10.3324/haematol.2019.220863

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Zhaoming Li, Yue Song, Yanjie Zhang, Chaoping Li, Yingjun Wang, Weili Xue, Lisha Lu, Mengyuan Jin, Zhiyuan Zhou, Xinhua Wang, Ling Li, Lei Zhang, Xin Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Hui Yu, Feifei Nan, Yu ChangJiaqin Yan, Xiaoyan Feng, Xiaolong Wu, Guannan Wang, Dandan Zhang, Wencai Li, Feixiang Li, Yuan Zhang, Ken H. Young, Mingzhi Zhang

Hematopathology

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	E107-E110
Journal	Haematologica
Volume	105
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2019.220863
State	Published - Mar 1 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2019.220863

Cite this

Li, Z, Song, Y, Zhang, Y, Li, C, Wang, Y, Xue, W, Lu, L, Jin, M, Zhou, Z, Wang, X, Li, L, Zhang, L, Li, X, Fu, X, Sun, Z, Wu, J, Zhang, X, Yu, H, Nan, F, Chang, Y, Yan, J, Feng, X, Wu, X, Wang, G, Zhang, D, Li, W, Li, F, Zhang, Y, Young, KH & Zhang, M 2020, 'Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma', Haematologica, vol. 105, no. 3, pp. E107-E110. https://doi.org/10.3324/haematol.2019.220863

@article{ef7a5987b01e490e9a96636f5a9aef56,

title = "Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma",

author = "Zhaoming Li and Yue Song and Yanjie Zhang and Chaoping Li and Yingjun Wang and Weili Xue and Lisha Lu and Mengyuan Jin and Zhiyuan Zhou and Xinhua Wang and Ling Li and Lei Zhang and Xin Li and Xiaorui Fu and Zhenchang Sun and Jingjing Wu and Xudong Zhang and Hui Yu and Feifei Nan and Yu Chang and Jiaqin Yan and Xiaoyan Feng and Xiaolong Wu and Guannan Wang and Dandan Zhang and Wencai Li and Feixiang Li and Yuan Zhang and Young, {Ken H.} and Mingzhi Zhang",

note = "Funding Information: This study was supported by funds from the National Natural Science Foundation of China (81570203), Innovation Funds Project of the First Affiliated Hospital of Zhengzhou University (to Mingzhi Zhang), the scientific and technological project from health and Family Planning Commission (201702047) and Department of Science, Technology of Henan province (182102310114). Funding Information: 1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;2Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China; 3Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;4Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;5Novogene Bioinformatics Technology Co., Ltd., Xueqing Road, Beijing, China;6The Academy of Medical Science of Zhengzhou University, Zhengzhou, China and 7Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Funding: this study was supported by funds from the National Natural Science Foundation of China (81570203), Innovation Funds Project of the First Affiliated Hospital of Zhengzhou University (to Mingzhi Zhang), the scientific and technological project from health and Family Planning Commission (201702047) and Department of Science, Technology of Henan province (182102310114). Acknowledgments: the authors gratefully acknowledge Dr. Tian Tian for critical review and language editing of the manuscript. Correspondence: MINGZHI ZHANG. mingzhi_zhang1@163.com doi:10.3324/haematol.2019.220863 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2020",

month = mar,

day = "1",

doi = "10.3324/haematol.2019.220863",

language = "English (US)",

volume = "105",

pages = "E107--E110",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

TY - JOUR

T1 - Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

AU - Li, Zhaoming

AU - Song, Yue

AU - Zhang, Yanjie

AU - Li, Chaoping

AU - Wang, Yingjun

AU - Xue, Weili

AU - Lu, Lisha

AU - Jin, Mengyuan

AU - Zhou, Zhiyuan

AU - Wang, Xinhua

AU - Li, Ling

AU - Zhang, Lei

AU - Li, Xin

AU - Fu, Xiaorui

AU - Sun, Zhenchang

AU - Wu, Jingjing

AU - Zhang, Xudong

AU - Yu, Hui

AU - Nan, Feifei

AU - Chang, Yu

AU - Yan, Jiaqin

AU - Feng, Xiaoyan

AU - Wu, Xiaolong

AU - Wang, Guannan

AU - Zhang, Dandan

AU - Li, Wencai

AU - Li, Feixiang

AU - Zhang, Yuan

AU - Young, Ken H.

AU - Zhang, Mingzhi

N1 - Funding Information: This study was supported by funds from the National Natural Science Foundation of China (81570203), Innovation Funds Project of the First Affiliated Hospital of Zhengzhou University (to Mingzhi Zhang), the scientific and technological project from health and Family Planning Commission (201702047) and Department of Science, Technology of Henan province (182102310114). Funding Information: 1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;2Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China; 3Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;4Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;5Novogene Bioinformatics Technology Co., Ltd., Xueqing Road, Beijing, China;6The Academy of Medical Science of Zhengzhou University, Zhengzhou, China and 7Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Funding: this study was supported by funds from the National Natural Science Foundation of China (81570203), Innovation Funds Project of the First Affiliated Hospital of Zhengzhou University (to Mingzhi Zhang), the scientific and technological project from health and Family Planning Commission (201702047) and Department of Science, Technology of Henan province (182102310114). Acknowledgments: the authors gratefully acknowledge Dr. Tian Tian for critical review and language editing of the manuscript. Correspondence: MINGZHI ZHANG. mingzhi_zhang1@163.com doi:10.3324/haematol.2019.220863 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85080934707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080934707&partnerID=8YFLogxK

U2 - 10.3324/haematol.2019.220863

DO - 10.3324/haematol.2019.220863

M3 - Letter

C2 - 31413085

AN - SCOPUS:85080934707

SN - 0390-6078

VL - 105

SP - E107-E110

JO - Haematologica

JF - Haematologica

IS - 3

ER -

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this